Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Disorders of Sex Development | 6 | 2020 | 71 | 0.610 |
Why?
|
| Puberty | 4 | 2016 | 104 | 0.360 |
Why?
|
| Calcium | 4 | 2005 | 1043 | 0.260 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2018 | 34 | 0.250 |
Why?
|
| Calcium, Dietary | 1 | 2004 | 37 | 0.210 |
Why?
|
| Androgen-Insensitivity Syndrome | 2 | 2015 | 26 | 0.180 |
Why?
|
| Terminology as Topic | 2 | 2020 | 227 | 0.160 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2019 | 866 | 0.150 |
Why?
|
| Patients | 1 | 2020 | 122 | 0.150 |
Why?
|
| Placental Extracts | 1 | 2018 | 1 | 0.150 |
Why?
|
| Attitude to Health | 1 | 2020 | 251 | 0.140 |
Why?
|
| Gender Identity | 2 | 2017 | 74 | 0.140 |
Why?
|
| Uterine Hemorrhage | 1 | 2018 | 42 | 0.140 |
Why?
|
| Breast Diseases | 1 | 2018 | 38 | 0.140 |
Why?
|
| Sex Counseling | 1 | 2017 | 6 | 0.130 |
Why?
|
| Mythology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Self-Management | 1 | 2019 | 117 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 262 | 0.130 |
Why?
|
| Camping | 1 | 2016 | 14 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2016 | 44 | 0.120 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.120 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 132 | 0.120 |
Why?
|
| Androgens | 2 | 2015 | 272 | 0.120 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 116 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 475 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2019 | 1103 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 1304 | 0.110 |
Why?
|
| Caregivers | 1 | 2020 | 585 | 0.100 |
Why?
|
| Fertility | 1 | 2016 | 266 | 0.100 |
Why?
|
| Insulin | 1 | 2019 | 1151 | 0.100 |
Why?
|
| Hypospadias | 1 | 2014 | 80 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 128 | 0.090 |
Why?
|
| Patient Care Team | 2 | 2016 | 558 | 0.080 |
Why?
|
| Consensus | 1 | 2012 | 557 | 0.070 |
Why?
|
| Inulin | 2 | 2005 | 17 | 0.070 |
Why?
|
| Fructans | 2 | 2005 | 12 | 0.070 |
Why?
|
| Familial Hypophosphatemic Rickets | 1 | 2007 | 7 | 0.070 |
Why?
|
| Child | 11 | 2019 | 26316 | 0.070 |
Why?
|
| Female | 16 | 2020 | 71221 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 80 | 0.060 |
Why?
|
| Brain | 1 | 2019 | 3236 | 0.060 |
Why?
|
| Hemangioendothelioma | 1 | 2007 | 25 | 0.060 |
Why?
|
| Humans | 21 | 2020 | 131781 | 0.060 |
Why?
|
| Vitamin D | 2 | 2005 | 194 | 0.060 |
Why?
|
| Adolescent | 8 | 2020 | 20994 | 0.060 |
Why?
|
| Hypothyroidism | 1 | 2007 | 78 | 0.060 |
Why?
|
| Calcification, Physiologic | 1 | 2005 | 24 | 0.060 |
Why?
|
| Respiratory Insufficiency | 1 | 2007 | 242 | 0.060 |
Why?
|
| Parathyroid Hormone | 1 | 2005 | 77 | 0.060 |
Why?
|
| Sexual Development | 2 | 2019 | 25 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1232 | 0.060 |
Why?
|
| Receptors, Calcitriol | 1 | 2005 | 59 | 0.050 |
Why?
|
| Calcium Isotopes | 1 | 2004 | 2 | 0.050 |
Why?
|
| Decision Making | 1 | 2009 | 687 | 0.050 |
Why?
|
| Intestinal Absorption | 1 | 2004 | 170 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2004 | 332 | 0.050 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 653 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 695 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 794 | 0.040 |
Why?
|
| Male | 11 | 2020 | 65290 | 0.040 |
Why?
|
| Pregnancy | 3 | 2018 | 7575 | 0.040 |
Why?
|
| Disclosure | 2 | 2015 | 149 | 0.040 |
Why?
|
| Infant | 5 | 2018 | 13324 | 0.040 |
Why?
|
| Feces | 1 | 2004 | 725 | 0.040 |
Why?
|
| Genetic Testing | 1 | 2007 | 1101 | 0.040 |
Why?
|
| Informed Consent | 2 | 2015 | 343 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 14 | 0.040 |
Why?
|
| Hormones | 1 | 2019 | 165 | 0.040 |
Why?
|
| Bone Density | 3 | 2005 | 362 | 0.040 |
Why?
|
| Goals | 1 | 2019 | 125 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2007 | 1133 | 0.030 |
Why?
|
| Greece, Ancient | 1 | 2017 | 9 | 0.030 |
Why?
|
| History, Ancient | 1 | 2017 | 53 | 0.030 |
Why?
|
| Breast | 1 | 2018 | 216 | 0.030 |
Why?
|
| Adolescent Behavior | 1 | 2019 | 170 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2018 | 235 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2018 | 234 | 0.030 |
Why?
|
| Health Planning Guidelines | 1 | 2016 | 33 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 41 | 0.030 |
Why?
|
| Liver Neoplasms | 1 | 2007 | 1393 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 263 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2019 | 469 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 62 | 0.030 |
Why?
|
| Gonads | 1 | 2015 | 32 | 0.030 |
Why?
|
| Genitalia | 1 | 2015 | 39 | 0.030 |
Why?
|
| Mothers | 1 | 2018 | 371 | 0.030 |
Why?
|
| Osteocalcin | 2 | 2005 | 45 | 0.030 |
Why?
|
| Genotype | 3 | 2005 | 2655 | 0.030 |
Why?
|
| Research | 1 | 2016 | 269 | 0.030 |
Why?
|
| Communication | 1 | 2019 | 531 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1457 | 0.030 |
Why?
|
| Placenta | 1 | 2018 | 528 | 0.030 |
Why?
|
| Estrogens | 1 | 2015 | 436 | 0.020 |
Why?
|
| Infant, Newborn | 2 | 2016 | 8597 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2015 | 15057 | 0.020 |
Why?
|
| Parents | 1 | 2019 | 1120 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3838 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 645 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 775 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 6279 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 4053 | 0.020 |
Why?
|
| Diet | 2 | 2005 | 1119 | 0.020 |
Why?
|
| PHEX Phosphate Regulating Neutral Endopeptidase | 1 | 2007 | 4 | 0.020 |
Why?
|
| Sex | 1 | 2007 | 7 | 0.020 |
Why?
|
| Phosphates | 1 | 2007 | 110 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2007 | 54 | 0.020 |
Why?
|
| Hernia, Inguinal | 1 | 2007 | 42 | 0.020 |
Why?
|
| Triiodothyronine | 1 | 2007 | 56 | 0.020 |
Why?
|
| Thyroxine | 1 | 2007 | 62 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2007 | 141 | 0.020 |
Why?
|
| Siblings | 1 | 2007 | 204 | 0.010 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 2005 | 7 | 0.010 |
Why?
|
| Absorption | 1 | 2005 | 50 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2005 | 57 | 0.010 |
Why?
|
| Phenotype | 1 | 2015 | 4528 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2014 | 12997 | 0.010 |
Why?
|
| Testis | 1 | 2007 | 413 | 0.010 |
Why?
|
| Heterozygote | 1 | 2007 | 728 | 0.010 |
Why?
|
| Placebos | 1 | 2005 | 227 | 0.010 |
Why?
|
| Immunoassay | 1 | 2005 | 133 | 0.010 |
Why?
|
| Adult | 2 | 2016 | 31710 | 0.010 |
Why?
|
| Polysaccharides | 1 | 2005 | 143 | 0.010 |
Why?
|
| Receptors, Androgen | 1 | 2007 | 419 | 0.010 |
Why?
|
| Texas | 1 | 2012 | 3622 | 0.010 |
Why?
|
| Pedigree | 1 | 2007 | 1712 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2005 | 955 | 0.010 |
Why?
|
| Kinetics | 1 | 2005 | 1104 | 0.010 |
Why?
|
| Bone and Bones | 1 | 2005 | 300 | 0.010 |
Why?
|
| Dietary Supplements | 1 | 2005 | 454 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 10965 | 0.010 |
Why?
|
| Neoplasms | 1 | 2015 | 2963 | 0.010 |
Why?
|
| Software | 1 | 2005 | 752 | 0.010 |
Why?
|
| United States | 1 | 2007 | 11815 | 0.010 |
Why?
|